Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04967508 |
|---|---|
| Brief Title: | A Study to Compare SB17 (Proposed Ustekinumab Biosimilar) to Stelara® in Subject With Moderate to Severe Plaque Psoriasis |
| First Submitted : | July 8, 2021 |
| First Submitted that Met QC Criteria : | July 8, 2021 |
| First Posted : | July 19, 2021 |
| Last Update Submitted that Met QC Criteria : | April 13, 2022 |
| Last Update Posted : | April 15, 2022 |